Fundraising FoxBeneVir Biopharm
Gaithersburg, US · Founded 2011 · Delaware corporation
Find your way into BeneVir Biopharm
Sign up to see every warm intro you have to BeneVir Biopharm
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BeneVir Biopharm team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BeneVir Biopharm was founded in 2011 by Matthew Charles Mulvey.
MC
Matthew Charles MulveyFounder
KA
Katherine Ann SackstederExecutive
Board
DK
David KirnBoard director
DP
David PresentBoard director
CP
Cherine PlumakerBoard director
Reported raises · per SEC filings
Form D private placements$11M disclosed across 3 rounds · 2014–2017
▶$2MraisedNov 2017 · 1 investors · BiotechnologyRule 506(b)
▶$2MraisedNov 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cherine PlumakerDirector
- Katherine Ann SackstederExecutive Officer, Director
- David PresentDirector
- Matthew Charles MulveyExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $2M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedAug 2016 · 1 investors · BiotechnologyRule 506(b)
▶$6MraisedAug 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Katherine Ann SackstederExecutive Officer, Director
- Matthew Charles MulveyExecutive Officer, Director
- David KirnDirector
- David PresentDirector
- Cherine PlumakerDirector
- Offering amount
- $12M
- Amount sold
- $6M
- Minimum investment
- $2M
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedFeb 2016 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedFeb 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David PresentDirector
- Matthew Charles MulveyExecutive Officer, Director
- David KirnDirector
- Katherine Ann SackstederExecutive Officer, Director
- Cherine PlumakerDirector
- Offering amount
- $12M
- Amount sold
- $3M
- Minimum investment
- $1M
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded BeneVir Biopharm?
- BeneVir Biopharm was founded by Matthew Charles Mulvey in 2011.
- How much funding has BeneVir Biopharm raised?
- BeneVir Biopharm has disclosed $11M raised across 3 rounds.
- Where is BeneVir Biopharm headquartered?
- BeneVir Biopharm is headquartered in Gaithersburg, US.